NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
VHC
VirnetX Holding Corp
There isn't enough reported data to score VHC yet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
VHC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Unavailable | |
| Strong |
VHC's revenue and balance sheet are currently strong, but its profitability is under pressure. There isn't enough data to rate its cash flow.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
VHC PE Valuation
VHC has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
VHC Forward outlook
There aren't enough analyst estimates for VHC to show an outlook.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over VHC on earnings quality, reporting a profit while its opponent remains loss making.
VHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$5.36 | -$0.57 |
| Q1 2026 | -$5.15 | -$0.28 |
| Q4 2025 | -$5.00 | +$0.05 |
| Q3 2023 | -$12.56 | -$6.56 |
| Q2 2023 | -$12.40 | -$6.60 |
| Q1 2023 | -$10.40 | -$4.80 |
| Q4 2022 | -$10.20 | +$1.80 |
| Q3 2022 | -$6.00 | +$5.60 |
VHC is still losing money, but far less than before: $5.36 per share over the past year, against $13.00 at its worst in early 2021.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over VHC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA's operating margin was 66% last quarter, up 5.4 points from the same quarter a year ago, near the top of its range since 2019.
VHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2025 | $58K | +2800% |
| Q2 2025 | $48K | +4700% |
| Q3 2024 | $2K | -33% |
| Q2 2024 | $1K | -50% |
| Q1 2024 | $2K | 0% |
| Q3 2023 | $3K | -25% |
| Q2 2023 | $2K | -94% |
| Q1 2023 | $2K | -60% |
VHC's revenue is growing: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -12152% | N/A |
| Q3 2025 | -8007% | +211343 points |
| Q2 2025 | -8217% | +433283 points |
| Q3 2024 | -219350% | -31517 points |
| Q2 2024 | -441500% | +164450 points |
| Q1 2024 | -246300% | +49400 points |
| Q3 2023 | -187833% | -53958 points |
| Q2 2023 | -605950% | -593400 points |
VHC's operating margin was −12152% last quarter, up 429348 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
VHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$4.3M | -$403K |
| Q4 2025 | -$5.8M | -$287K |
| Q3 2025 | -$3M | +$200K |
| Q1 2025 | -$3.9M | -$378K |
| Q4 2024 | -$5.5M | +$1.5M |
| Q3 2024 | -$3.2M | +$70K |
| Q1 2024 | -$3.5M | -$805K |
| Q2 2023 | -$11.8M | -$8.4M |
VHC has burned cash in almost every quarter: −$17M over the past year, against −$19M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over VHC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
VHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +16K shares |
| 1 year | +3.9% | +143K shares |
| 3 years | +5.6% | +199K shares |
| 5 years | +6.1% | +217K shares |
| Available history | +9.4% | +323K shares |
VHC has 4M diluted shares, up 3.9% from a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2020 | -1.2x | Net Cash |
| Q3 2020 | -1.4x | Net Cash |
| Q2 2020 | -1.7x | Net Cash |
| Q1 2020 | -2.6x | Net Cash |
VHC has more cash than debt.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
VHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.4 | Neutral |
| Stochastic | 14.7 | Oversold |
VHC's weekly RSI is 39 (neutral) and its Stochastic is 15 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
VHC PE vs Technology Sector
| Metric | VHC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
VHC has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over VHC on trend strength, trading above more of its moving averages.
VHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.2 | 5.6% below |
| 20 week MA | $11.6 | 17% below |
| 50 week MA | $14.5 | 33% below |
| 100 week MA | $13.6 | 29% below |
| 200 week MA | $12.6 | 23% below |
VHC is in a downtrend: it's below all five of its weekly moving averages, and 23% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over VHC on returns for 2026, with the stronger performance.
VHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $76.8 | $105.0 | +37% |
| 2021 | $105.0 | $57.6 | -45% |
| 2022 | $57.6 | $24.0 | -58% |
| 2023 | $24.0 | $7.00 | -71% |
| 2024 | $7.00 | $5.25 | -25% |
| 2025 | $5.25 | $18.0 | +243% |
| 2026 YTD | $18.0 | $9.65 | -46% |
VHC's yearly returns have swung widely, from +243% in 2025 to −71% in 2023. It's down 46% so far in 2026.